A detailed history of Heron Bay Capital Management transactions in Incyte Corp stock. As of the latest transaction made, Heron Bay Capital Management holds 15,006 shares of INCY stock, worth $1.05 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
15,006
Previous 14,900 0.71%
Holding current value
$1.05 Million
Previous $903,000 9.75%
% of portfolio
0.21%
Previous 0.2%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$57.33 - $68.61 $6,076 - $7,272
106 Added 0.71%
15,006 $991,000
Q2 2024

Aug 13, 2024

SELL
$51.18 - $63.75 $329,701 - $410,677
-6,442 Reduced 30.18%
14,900 $903,000
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $496,056 - $584,127
8,772 Added 69.79%
21,342 $1.22 Million
Q4 2023

Jan 12, 2024

BUY
$52.16 - $64.19 $4,798 - $5,905
92 Added 0.74%
12,570 $789,000
Q3 2023

Nov 01, 2023

SELL
$57.77 - $65.93 $140,207 - $160,012
-2,427 Reduced 16.28%
12,478 $720,000
Q2 2023

Jul 12, 2023

BUY
$60.95 - $75.51 $572,747 - $709,567
9,397 Added 170.61%
14,905 $927,000
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $386,826 - $473,743
5,508 New
5,508 $398,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Heron Bay Capital Management Portfolio

Follow Heron Bay Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Heron Bay Capital Management with notifications on news.